Practice Management News

In a letter to CMS, the ACP voiced its support of the Center for Medicare and Medicaid Innovation’s move towards value-based payment models, but also expressed several significant reservations on the testing approaches for new payment models, as well as their impact on disadvantaged patients.

Opioid use is not associated with an increased risk for Alzheimer’s disease, according to findings recently published in Pain Medicine.

Perspectum Diagnostics Ltd. received 510(k) clearance from the FDA for LiverMultiScan, a post-processing software device for MRI of the liver, which will expand its access to more patients with liver disorders who can benefit from non-invasive diagnostic aid, according to a press release.

Collaboration between local specialty pharmacies, providers and patients minimized time to therapy, lowered rates of direct-acting antiviral denial, facilitated patient financial assistance and helped optimize clinical outcomes, according to a recently published study.

Intranasal or intramuscular naloxone administered by emergency medical services personnel effectively reversed opioid overdose symptoms without serious adverse events, according to data published in Annals of Internal Medicine.

Officials with VA medical centers often failed to report health care providers who faced review after questions were raised about their clinical care, according to a report released by the Government Accountability Office, or GAO.

Today, the FDA revealed its newest action to reduce the span of the opioid abuse and addiction crisis — guidance to assist the development of generic versions of approved opioids formulated to deter abuse.

Increasing access to meaningful information, including price, cost and quality data on health care services, can aid in efforts to improve health care price transparency and may help mend the health care fragmentation, according to a new policy paper by the ACP.

Unlimited, immediate access to opioid agonist treatment with methadone for patients with opioid use disorder offers drastic cost savings and greater health benefits compared with the standard of care, according to a study published in Annals of Internal Medicine.

WASHINGTON — When diagnosed with Hodgkin lymphoma at the age of 33 years, FDA Commissioner Scott Gottlieb, MD, was told he had a 90% chance of survival.